New kidney stone surgery aims for cleaner removal
NCT ID NCT07172373
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 2 times
Summary
This study compares a new surgical technique, antegrade flexible ureteroscopy-assisted PCNL, to standard PCNL for removing large, branching kidney stones (staghorn calculi). The goal is to see if the new method removes more stone fragments and causes fewer complications. The trial will enroll 420 adults across multiple centers, randomly assigning them to one of the two procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
antegrade flexible ureteroscopy-assisted PCNL (surgical procedure)
What this could lead to
If successful, this could offer a more effective and safer surgical option for removing large, branching kidney stones, potentially reducing the need for repeat procedures.
What could go wrong
This is a surgical technique study, not a new drug. The benefit may be modest, and surgery always carries risks like bleeding or infection. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROLITHIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••